biOasis Technologies receives patent for blood-brain barrier tech; Medical marijuana co. plans drug discovery platform;

> biOasis Technologies announced a U.S. patent covering "the delivery of therapeutic agents by using polypeptides from the company's Transcend BBB (blood-brain barrier) delivery vector." More

> Medical marijuana company CannaPharmaRx announced plans for its CannaSyn technology to rapid, targeted new molecule discovery and production. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.